Gregg Gilbert analyst

Currently out of the existing stock ratings of Gregg Gilbert, 157 are a BUY (72.35%), 59 are a HOLD (27.19%), 1 are a SELL (0.46%).

Gregg Gilbert

Work Performance Price Targets & Ratings Chart

Analyst Gregg Gilbert, carries an average stock price target met ratio of 64.84% that have a potential upside of 33.54% achieved within 349 days. Previously, Gregg Gilbert worked at TRUIST, DEUTSCHE BANK, BAML.

Gregg Gilbert’s has documented 437 price targets and ratings displayed on 32 stocks. The coverage was on Healthcare, Energy sectors.

Most recent stock forecast was given on COLL, Collegium Pharmaceutical at 07-Aug-2025.

Wall Street Analyst Gregg Gilbert

Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 2/24/2021. The price target of $12 was fulfilled within 2 days with a profit of $0.54 (4.71%) receiving and performance score of 23.56.

Average potential price target upside

ABBV AbbVie AGN Allergan plc AKRX Akorn AMAG AMAG Pharmaceuticals ARQT Arcutis Biotherapeutics  ATRS Antares Pharma BHC Bausch Health Companies ENDP Endo International PLC EOLS Evolus JAZZ Jazz Pharmaceuticals PLC LCI Lannett Company LGND Ligand Pharmaceuticals LLY Eli Lilly and Company MNK Mallinckrodt plc MRK Merck mpany MYL Viatris NVCR Novocure Ltd PFE Pfizer PRGO Perrigo Company PLC TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis BMY Bristol-Myers Squibb Company COLL Collegium Pharmaceutical AMRX Amneal Pharmaceuticals, Common Stock VTRS Viatris SGNT Sagent Pharmaceuticals DHT DHT Holdings AERI Aerie Pharmaceuticals PCRX Pacira Pharmaceuticals ACT Enact Holdings AM Antero Midstream Partners LP CHRS Coherus BioSciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Sep-2026

$315

$57.88 (22.51%)

$265

Buy Since 12-Sep-2025

$303

$45.88 (17.84%)

$298

26 days ago
(20-Aug-2026)

2/8 (25%)

$41.17 (15.72%)

35

Buy Since 08-Dec-2021

$300

$42.88 (16.68%)

$295

29 days ago
(17-Aug-2026)

9/11 (81.82%)

$49.67 (19.84%)

469

Buy Since 23-Jan-2023

$260

$2.88 (1.12%)

$235

1 months 5 days ago
(10-Aug-2026)

9/9 (100%)

$12.03 (4.85%)

127

Buy Since 06-Feb-2020

$288

$30.88 (12.01%)

$261

1 months 11 days ago
(04-Aug-2026)

36/37 (97.3%)

$44.2 (18.13%)

434

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?